116
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Ischemic ECG abnormalities are associated with an increased risk for death among subjects with COPD, also among those without known heart disease

, , , , &
Pages 2507-2514 | Published online: 22 Aug 2017

References

  • WHOThe top 10 causes of death [internet]Fact sheet N°310GenevaWHO2014 Available from: http://www.who.int/mediacentre/factsheets/fs310/en/Accessed October 05, 2016
  • ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
  • CamiciottoliGBigazziFMagniCPrevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2016112229223627695310
  • MüllerovaHAgustiAErqouSMapelDWCardiovascular comorbidity in COPD: systematic literature reviewChest201314441163117823722528
  • FinkelsteinJChaEScharfSMChronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidityInt J Chron Obstruct Pulmon Dis2009433734919802349
  • YinLLensmarCIngelssonEBackMDifferential association of chronic obstructive pulmonary disease with myocardial infarction and ischemic stroke in a nation-wide cohortInt J Cardiol2014173360160324704409
  • MenezesAMPérez-PadillaRWehrmeisterFCPLATINO teamFEV1 is a better predictor of mortality than FVC: the PLATINO cohort studyPLoS One2014910e10973225285441
  • LindbergALarssonLGMuellerovaHRönmarkELundbäckBUp-to-date on mortality in COPD – report from the OLIN COPD studyBMC Pulm Med201212122230685
  • ManninoDMBuistASPettyTLEnrightPLReddSCLung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up studyThorax200358538839312728157
  • From the Global Strategy for the Diagnosis MaPoCGlobal Initiative for Chronic Obstructive Lung Disease (GOLD)2017 Available from: http://www.goldcopd.orgAccessed June 30, 2017
  • BerryCEWiseRAMortality in COPD: causes, risk factors, and preventionCOPD20107537538220854053
  • SinDDWuLManSFThe relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literatureChest200512761952195915947307
  • JørgensenPGJensenJSMarottJLJensenGBAppleyardMMogelvangRElectrocardiographic changes improve risk prediction in asymptomatic persons age 65 years or above without cardiovascular diseaseJ Am Coll Cardiol201464989890625169175
  • OstörESchnohrPJensenGNyboeJHansenATElectrocardiographic findings and their association with mortality in the Copenhagen City Heart StudyEur Heart J1981243173287297572
  • De BacquerDDe BackerGKornitzerMBlackburnHPrognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and womenHeart199880657057710065025
  • RollinAMauryPKeeFIsolated negative T waves in the general population is a powerful predicting factor of cardiac mortality and coronary heart diseaseInt J Cardiol201620331832426523363
  • AuerRBauerDCMarques-VidalPHealth ABC StudyAssociation of major and minor ECG abnormalities with coronary heart disease eventsJAMA2012307141497150522496264
  • ChouRAroraBDanaTFuRWalkerMHumphreyLScreening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. Preventive Services Task ForceAnn Intern Med2011155637538521930855
  • VanfleterenLEFranssenFMUszko-LencerNHFrequency and relevance of ischemic electrocardiographic findings in patients with chronic obstructive pulmonary diseaseAm J Cardiol2011108111669167422077976
  • NilssonUJohanssonBErikssonBBlombergALundbäckBLindbergAIschemic heart disease among subjects with and without chronic obstructive pulmonary disease – ECG-findings in a population-based cohort studyBMC Pulm Med20151515626637314
  • LangePMogelvangRMarottJLVestboJJensenJSCardiovascular morbidity in COPD: a study of the general populationCOPD20107151020214458
  • Antonelli IncalziRFusoLDe RosaMCo-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary diseaseEur Respir J19971012279428009493663
  • LindbergALundbäckBThe Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortalityClin Respir J20082Suppl 1647120298352
  • PrineasRJCrowRSBlackburnHWThe Minnesota code manual of electrocardiographic findings: standards and procedures for measurement and classificationBoston, MAJohn Wright-PSG1982
  • Standardization of Spirometry, 1994 Update. American Thoracic SocietyAm J Respir Crit Care Med19951523110711367663792
  • BackmanHLindbergAOdénAReference values for spirometry – report from the Obstructive Lung Disease in Northern Sweden studiesEur Clin Respir J2015226375
  • CollSBetriuAde FloresTSignificance of Q-wave regression after transmural acute myocardial infarctionAm J Cardiol198861107397423354435
  • KurlSMakikallioTHLaukkanenJAT-wave inversion and mortality riskAnn Med2015471697325613172
  • GoudisCAKonstantinidisAKNtalasIVKorantzopoulosPElectrocardiographic abnormalities and cardiac arrhythmias in chronic obstructive pulmonary diseaseInt J Cardiol201519926427326218181
  • LamprechtBSorianoJBStudnickaMDeterminants of underdiagnosis of COPD in national and international surveysChest2015148497198525950276
  • JohnstonAKManninoDMHaganGWDavisKJKiriVARelationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohortThorax200863759960518245145
  • FranssenFMSorianoJBRocheNLung function abnormalities in smokers with ischemic heart diseaseAm J Respir Crit Care Med2016194556857627442601
  • CampoGGuastarobaPMarzocchiAImpact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary interventionChest2013144375075723392738
  • WakabayashiKGonzalezMADelhayeCImpact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarctionAm J Cardiol2010106330530920643237
  • AndellPKoulSMartinssonAImpact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarctionOpen Heart201411e00000225332773
  • MiravitllesMVogelmeierCRocheNA review of national guidelines for management of COPD in EuropeEur Respir J201647262563726797035
  • MoyerVAU.S. Preventive Services Task Force. Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statementAnn Intern Med2012157751251822847227
  • ShahAJVaccarinoVJanssensACAn electrocardiogram-based risk equation for incident cardiovascular disease from the National Health and Nutrition Examination SurveyJAMA Cardiol20161777978627487404
  • SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: role of comorbiditiesEur Respir J20062861245125717138679
  • ErikssonBLindbergAMüllerovaHRönmarkELundbäckBAssociation of heart diseases with COPD and restrictive lung function – results from a population surveyRespir Med201310719810623127573
  • FordESWheatonAGManninoDMPresley-CantrellLLiCCroftJBElevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007–2010Respir Res20121311523237325
  • BackmanHErikssonBHedmanLRestrictive spirometric pattern in the general adult population: methods of defining the condition and consequences on prevalenceRespir Med201612011612327817808
  • HardieJABuistASVollmerWMEllingsenIBakkePSMørkveORisk of over-diagnosis of COPD in asymptomatic elderly never-smokersEur Respir J20022051117112212449163